GeneDx Holdings Corp. (NASDAQ: WGS)
$32.04
-2.4600 ( -7.13% ) 607.8K
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.
Market Data
Open
$32.04
Previous close
$34.50
Volume
607.8K
Market cap
$838.40M
Day range
$31.85 - $36.15
52 week range
$1.16 - $36.15
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 12, 2023 |
4 | Insider transactions | 1 | Sep 12, 2023 |
4 | Insider transactions | 1 | Sep 12, 2023 |
4 | Insider transactions | 1 | Sep 06, 2023 |
4 | Insider transactions | 1 | Aug 18, 2023 |
10-q | Quarterly Reports | 103 | Aug 08, 2023 |
8-k | 8K-related | 21 | Aug 08, 2023 |
4 | Insider transactions | 1 | Jul 27, 2023 |
4 | Insider transactions | 2 | Jul 25, 2023 |
4 | Insider transactions | 1 | Jul 25, 2023 |